Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Desoubeaux, Guillaume, Reichert, Janice M., Sleeman, Matthew, Reckamp, Karen L., Ryffel, Bernhard, Adamczewski, Jörg P., Sweeney, Theresa D., Vanbever, Rita, Diot, Patrice, Owen, Caroline A., Page, Clive, Lerondel, Stéphanie, Le Pape, Alain, Heuze-Vourc'h, Nathalie
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Meeting Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968091/
https://ncbi.nlm.nih.gov/pubmed/27266390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1196521
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados